Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration

Michael W. DeGregorio, Bruce J. Wilbur, Ester Coronado, C. Kent Osborne

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. We hav examined the steady-state serum tamoxifen concentrations achieved in mice with s. c. slow-release pellets, s. c. injections, and i. p. injections, in an attempt to identify a method that would yield serum levels similar to those observed in patients receiving tamoxifen therapy. Tamoxifen and tamoxifen metabolites were examined by a high-performance liquid chromatography assay which has a sensitivity of 8 ng/ml. Tamoxifen metabolites were not observed with any dose or schedule. After slow-release pellets containing 5 or 25 mg tamoxifen no tamoxifen was detectable, even after 2 weeks of treatment. Very low levels (0.07 μM) were found with 50-mg pellets. Tamoxifen was also not detected either with daily s. c. injections of 500 μg/mouse or with i. p. injections of 2.5 mg/kg. However, daily s. c. injections of 1000 μg or i. p. injections of 25, 50, o4 100 mg/kg resulted in tamoxifen concentrations ranging from 0.21 to 0.51 μM which are similar to those observed in patients. Thus, clinically relevant tamoxifen concentrations can be achieved in the nude mouse with either of these methods of administration.

Original languageEnglish (US)
Pages (from-to)316-318
Number of pages3
JournalCancer Chemotherapy and Pharmacology
Volume20
Issue number4
DOIs
StatePublished - Dec 1987

Fingerprint

Tamoxifen
Nude Mice
Serum
Injections
Metabolites
Estrogen Receptor Modulators
High performance liquid chromatography
Assays
Appointments and Schedules
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration. / DeGregorio, Michael W.; Wilbur, Bruce J.; Coronado, Ester; Osborne, C. Kent.

In: Cancer Chemotherapy and Pharmacology, Vol. 20, No. 4, 12.1987, p. 316-318.

Research output: Contribution to journalArticle

DeGregorio, Michael W. ; Wilbur, Bruce J. ; Coronado, Ester ; Osborne, C. Kent. / Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration. In: Cancer Chemotherapy and Pharmacology. 1987 ; Vol. 20, No. 4. pp. 316-318.
@article{bc276189b2f641b99bd3c7b0074df79f,
title = "Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration",
abstract = "The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. We hav examined the steady-state serum tamoxifen concentrations achieved in mice with s. c. slow-release pellets, s. c. injections, and i. p. injections, in an attempt to identify a method that would yield serum levels similar to those observed in patients receiving tamoxifen therapy. Tamoxifen and tamoxifen metabolites were examined by a high-performance liquid chromatography assay which has a sensitivity of 8 ng/ml. Tamoxifen metabolites were not observed with any dose or schedule. After slow-release pellets containing 5 or 25 mg tamoxifen no tamoxifen was detectable, even after 2 weeks of treatment. Very low levels (0.07 μM) were found with 50-mg pellets. Tamoxifen was also not detected either with daily s. c. injections of 500 μg/mouse or with i. p. injections of 2.5 mg/kg. However, daily s. c. injections of 1000 μg or i. p. injections of 25, 50, o4 100 mg/kg resulted in tamoxifen concentrations ranging from 0.21 to 0.51 μM which are similar to those observed in patients. Thus, clinically relevant tamoxifen concentrations can be achieved in the nude mouse with either of these methods of administration.",
author = "DeGregorio, {Michael W.} and Wilbur, {Bruce J.} and Ester Coronado and Osborne, {C. Kent}",
year = "1987",
month = "12",
doi = "10.1007/BF00262583",
language = "English (US)",
volume = "20",
pages = "316--318",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration

AU - DeGregorio, Michael W.

AU - Wilbur, Bruce J.

AU - Coronado, Ester

AU - Osborne, C. Kent

PY - 1987/12

Y1 - 1987/12

N2 - The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. We hav examined the steady-state serum tamoxifen concentrations achieved in mice with s. c. slow-release pellets, s. c. injections, and i. p. injections, in an attempt to identify a method that would yield serum levels similar to those observed in patients receiving tamoxifen therapy. Tamoxifen and tamoxifen metabolites were examined by a high-performance liquid chromatography assay which has a sensitivity of 8 ng/ml. Tamoxifen metabolites were not observed with any dose or schedule. After slow-release pellets containing 5 or 25 mg tamoxifen no tamoxifen was detectable, even after 2 weeks of treatment. Very low levels (0.07 μM) were found with 50-mg pellets. Tamoxifen was also not detected either with daily s. c. injections of 500 μg/mouse or with i. p. injections of 2.5 mg/kg. However, daily s. c. injections of 1000 μg or i. p. injections of 25, 50, o4 100 mg/kg resulted in tamoxifen concentrations ranging from 0.21 to 0.51 μM which are similar to those observed in patients. Thus, clinically relevant tamoxifen concentrations can be achieved in the nude mouse with either of these methods of administration.

AB - The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. We hav examined the steady-state serum tamoxifen concentrations achieved in mice with s. c. slow-release pellets, s. c. injections, and i. p. injections, in an attempt to identify a method that would yield serum levels similar to those observed in patients receiving tamoxifen therapy. Tamoxifen and tamoxifen metabolites were examined by a high-performance liquid chromatography assay which has a sensitivity of 8 ng/ml. Tamoxifen metabolites were not observed with any dose or schedule. After slow-release pellets containing 5 or 25 mg tamoxifen no tamoxifen was detectable, even after 2 weeks of treatment. Very low levels (0.07 μM) were found with 50-mg pellets. Tamoxifen was also not detected either with daily s. c. injections of 500 μg/mouse or with i. p. injections of 2.5 mg/kg. However, daily s. c. injections of 1000 μg or i. p. injections of 25, 50, o4 100 mg/kg resulted in tamoxifen concentrations ranging from 0.21 to 0.51 μM which are similar to those observed in patients. Thus, clinically relevant tamoxifen concentrations can be achieved in the nude mouse with either of these methods of administration.

UR - http://www.scopus.com/inward/record.url?scp=0023501880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023501880&partnerID=8YFLogxK

U2 - 10.1007/BF00262583

DO - 10.1007/BF00262583

M3 - Article

C2 - 3690805

AN - SCOPUS:0023501880

VL - 20

SP - 316

EP - 318

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 4

ER -